Matches in SemOpenAlex for { <https://semopenalex.org/work/W2039175046> ?p ?o ?g. }
Showing items 1 to 83 of
83
with 100 items per page.
- W2039175046 endingPage "216" @default.
- W2039175046 startingPage "215" @default.
- W2039175046 abstract "Even though there are multiple options for the treatment of asthma, there still exists a fair group of patients with difficult-to-control asthma. We describe for the first time the real-world effects of three-year omalizumab treatment on patients with difficult-to-control asthma, seen in a social security hospital in a Latin American country.Difficult-to-control asthmatic patients from the out-patient clinic of a regional hospital were recruited to receive a three-year omalizumab course. Efficacy parameters were asthma control test (ACT) score; FEV1; daily beclomethasone maintenance dose; and unplanned visits for asthma exacerbations (emergency room (ER), hospitalisations, intensive care).52 patients were recruited, 47 completed the three-year treatment (42 female, 15–67 years, mean age 43.5). Comparing efficacy parameters of the year before omalizumab with the 3rd year of omalizumab: mean ACT improved from 12.4 to 20.5, mean FEV1 from 66.3% (standard deviation (SD) 19.1%) to 88.4% (SD 16.2%) of predicted, while mean beclomethasone dose reduced from 1750 to 766 mcg/day and there was a significant reduction in patients experiencing ER visits (from 95% to 19%, p < 0.0001), hospitalisation (38% to 2%, p < 0.0001) and intensive care (4% to 0, NS). Five patients discontinued omalizumab, two because of an adverse event (anaphylaxis, severe headache, both resolved without sequelae).Omalizumab improved most clinical parameters of Mexican patients with difficult-to-control asthma. Especially the rates of ER visits and hospitalisation were significantly reduced, thus reducing costs. Omalizumab was generally well tolerated." @default.
- W2039175046 created "2016-06-24" @default.
- W2039175046 creator A5013233505 @default.
- W2039175046 creator A5064320272 @default.
- W2039175046 creator A5080640228 @default.
- W2039175046 date "2015-03-01" @default.
- W2039175046 modified "2023-10-01" @default.
- W2039175046 title "Are skin prick tests really safe? A case of anaphylaxis caused by skin prick testing with inhalant allergens" @default.
- W2039175046 cites W1970191171 @default.
- W2039175046 cites W1981080715 @default.
- W2039175046 cites W2000359324 @default.
- W2039175046 cites W2021341962 @default.
- W2039175046 cites W2021910833 @default.
- W2039175046 cites W2050552280 @default.
- W2039175046 cites W2164132449 @default.
- W2039175046 doi "https://doi.org/10.1016/j.aller.2013.09.011" @default.
- W2039175046 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/24485940" @default.
- W2039175046 hasPublicationYear "2015" @default.
- W2039175046 type Work @default.
- W2039175046 sameAs 2039175046 @default.
- W2039175046 citedByCount "4" @default.
- W2039175046 countsByYear W20391750462016 @default.
- W2039175046 countsByYear W20391750462017 @default.
- W2039175046 countsByYear W20391750462022 @default.
- W2039175046 countsByYear W20391750462023 @default.
- W2039175046 crossrefType "journal-article" @default.
- W2039175046 hasAuthorship W2039175046A5013233505 @default.
- W2039175046 hasAuthorship W2039175046A5064320272 @default.
- W2039175046 hasAuthorship W2039175046A5080640228 @default.
- W2039175046 hasConcept C118552586 @default.
- W2039175046 hasConcept C126322002 @default.
- W2039175046 hasConcept C141105273 @default.
- W2039175046 hasConcept C159654299 @default.
- W2039175046 hasConcept C187212893 @default.
- W2039175046 hasConcept C194828623 @default.
- W2039175046 hasConcept C197934379 @default.
- W2039175046 hasConcept C203014093 @default.
- W2039175046 hasConcept C207480886 @default.
- W2039175046 hasConcept C2775933838 @default.
- W2039175046 hasConcept C2776042228 @default.
- W2039175046 hasConcept C2778564945 @default.
- W2039175046 hasConcept C2778570526 @default.
- W2039175046 hasConcept C2780724011 @default.
- W2039175046 hasConcept C3020633164 @default.
- W2039175046 hasConcept C71924100 @default.
- W2039175046 hasConceptScore W2039175046C118552586 @default.
- W2039175046 hasConceptScore W2039175046C126322002 @default.
- W2039175046 hasConceptScore W2039175046C141105273 @default.
- W2039175046 hasConceptScore W2039175046C159654299 @default.
- W2039175046 hasConceptScore W2039175046C187212893 @default.
- W2039175046 hasConceptScore W2039175046C194828623 @default.
- W2039175046 hasConceptScore W2039175046C197934379 @default.
- W2039175046 hasConceptScore W2039175046C203014093 @default.
- W2039175046 hasConceptScore W2039175046C207480886 @default.
- W2039175046 hasConceptScore W2039175046C2775933838 @default.
- W2039175046 hasConceptScore W2039175046C2776042228 @default.
- W2039175046 hasConceptScore W2039175046C2778564945 @default.
- W2039175046 hasConceptScore W2039175046C2778570526 @default.
- W2039175046 hasConceptScore W2039175046C2780724011 @default.
- W2039175046 hasConceptScore W2039175046C3020633164 @default.
- W2039175046 hasConceptScore W2039175046C71924100 @default.
- W2039175046 hasIssue "2" @default.
- W2039175046 hasLocation W20391750461 @default.
- W2039175046 hasLocation W20391750462 @default.
- W2039175046 hasOpenAccess W2039175046 @default.
- W2039175046 hasPrimaryLocation W20391750461 @default.
- W2039175046 hasRelatedWork W1835748109 @default.
- W2039175046 hasRelatedWork W2025742193 @default.
- W2039175046 hasRelatedWork W2026095104 @default.
- W2039175046 hasRelatedWork W2036652080 @default.
- W2039175046 hasRelatedWork W2040467401 @default.
- W2039175046 hasRelatedWork W2188676310 @default.
- W2039175046 hasRelatedWork W2550157314 @default.
- W2039175046 hasRelatedWork W2596614673 @default.
- W2039175046 hasRelatedWork W2810305518 @default.
- W2039175046 hasRelatedWork W2891833500 @default.
- W2039175046 hasVolume "43" @default.
- W2039175046 isParatext "false" @default.
- W2039175046 isRetracted "false" @default.
- W2039175046 magId "2039175046" @default.
- W2039175046 workType "article" @default.